Paradigm Biocapital Advisors LP

Q3 2025 13F Holdings

  • Location
    new york, NY
  • Num holdings

    36

  • Value ($000)

    $3,516,197

  • Date Filed
    11/14/2025
  • Form type
    13F-HR
  • CIK
    0001855655
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
N
NUVL

NUVALENT INC

COM
670703107
$455.70M
13 %

5,269,433

---

MERUS N V

COM
N5749R100
$411.79M
12 %

4,373,770

A
ACLX

ARCELLX INC

COMMON STOCK
03940C100
$381.68M
11 %

4,649,016

R
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$290.63M
8 %

6,223,291

T
TARS

TARSUS PHARMACEUTICALS INC

COM
87650L103
$158.42M
5 %

2,665,698

P
PCVX

VAXCYTE INC

COM
92243G108
$136.33M
4 %

3,784,755

---

ABIVAX SA

SPONSORED ADS
00370M103
$132.80M
4 %

1,564,196

G
GMAB

GENMAB A/S

SPONSORED ADS
372303206
$117.06M
3 %

3,816,851

A
AGIO

AGIOS PHARMACEUTICALS INC

COM
00847X104
$107.32M
3 %

2,673,555

C
CRNX

CRINETICS PHARMACEUTICALS IN

COM
22663K107
$106.24M
3 %

2,550,774

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 36